Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Global Felodipine Sustained-Release Tablet Market Growth 2024-2030

Report ID: 2901203 | Published Date: May 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
1 Scope of the Report

    1.1 Market Introduction

    1.2 Years Considered

    1.3 Research Objectives

    1.4 Market Research Methodology

    1.5 Research Process and Data Source

    1.6 Economic Indicators

    1.7 Currency Considered

    1.8 Market Estimation Caveats

2 Executive Summary

    2.1 World Market Overview

        2.1.1 Global Felodipine Sustained-Release Tablet Annual Sales 2019-2030

        2.1.2 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Geographic Region, 2019, 2023 & 2030

        2.1.3 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Country/Region, 2019, 2023 & 2030

    2.2 Felodipine Sustained-Release Tablet Segment by Type

        2.2.1 2.5mg Per Tablet

        2.2.2 5mg Per Tablet

        2.2.3 Others

    2.3 Felodipine Sustained-Release Tablet Sales by Type

        2.3.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)

        2.3.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Type (2019-2024)

        2.3.3 Global Felodipine Sustained-Release Tablet Sale Price by Type (2019-2024)

    2.4 Felodipine Sustained-Release Tablet Segment by Application

        2.4.1 Treat High Blood Pressure

        2.4.2 Relieve Angina

        2.4.3 Others

    2.5 Felodipine Sustained-Release Tablet Sales by Application

        2.5.1 Global Felodipine Sustained-Release Tablet Sale Market Share by Application (2019-2024)

        2.5.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Application (2019-2024)

        2.5.3 Global Felodipine Sustained-Release Tablet Sale Price by Application (2019-2024)

3 Global Felodipine Sustained-Release Tablet by Company

    3.1 Global Felodipine Sustained-Release Tablet Breakdown Data by Company

        3.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Company (2019-2024)

        3.1.2 Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2019-2024)

    3.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Company (2019-2024)

        3.2.1 Global Felodipine Sustained-Release Tablet Revenue by Company (2019-2024)

        3.2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2019-2024)

    3.3 Global Felodipine Sustained-Release Tablet Sale Price by Company

    3.4 Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution, Sales Area, Product Type

        3.4.1 Key Manufacturers Felodipine Sustained-Release Tablet Product Location Distribution

        3.4.2 Players Felodipine Sustained-Release Tablet Products Offered

    3.5 Market Concentration Rate Analysis

        3.5.1 Competition Landscape Analysis

        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    3.6 New Products and Potential Entrants

    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Felodipine Sustained-Release Tablet by Geographic Region

    4.1 World Historic Felodipine Sustained-Release Tablet Market Size by Geographic Region (2019-2024)

        4.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Geographic Region (2019-2024)

        4.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Geographic Region (2019-2024)

    4.2 World Historic Felodipine Sustained-Release Tablet Market Size by Country/Region (2019-2024)

        4.2.1 Global Felodipine Sustained-Release Tablet Annual Sales by Country/Region (2019-2024)

        4.2.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Country/Region (2019-2024)

    4.3 Americas Felodipine Sustained-Release Tablet Sales Growth

    4.4 APAC Felodipine Sustained-Release Tablet Sales Growth

    4.5 Europe Felodipine Sustained-Release Tablet Sales Growth

    4.6 Middle East & Africa Felodipine Sustained-Release Tablet Sales Growth

5 Americas

    5.1 Americas Felodipine Sustained-Release Tablet Sales by Country

        5.1.1 Americas Felodipine Sustained-Release Tablet Sales by Country (2019-2024)

        5.1.2 Americas Felodipine Sustained-Release Tablet Revenue by Country (2019-2024)

    5.2 Americas Felodipine Sustained-Release Tablet Sales by Type

    5.3 Americas Felodipine Sustained-Release Tablet Sales by Application

    5.4 United States

    5.5 Canada

    5.6 Mexico

    5.7 Brazil

6 APAC

    6.1 APAC Felodipine Sustained-Release Tablet Sales by Region

        6.1.1 APAC Felodipine Sustained-Release Tablet Sales by Region (2019-2024)

        6.1.2 APAC Felodipine Sustained-Release Tablet Revenue by Region (2019-2024)

    6.2 APAC Felodipine Sustained-Release Tablet Sales by Type

    6.3 APAC Felodipine Sustained-Release Tablet Sales by Application

    6.4 China

    6.5 Japan

    6.6 South Korea

    6.7 Southeast Asia

    6.8 India

    6.9 Australia

    6.10 China Taiwan

7 Europe

    7.1 Europe Felodipine Sustained-Release Tablet by Country

        7.1.1 Europe Felodipine Sustained-Release Tablet Sales by Country (2019-2024)

        7.1.2 Europe Felodipine Sustained-Release Tablet Revenue by Country (2019-2024)

    7.2 Europe Felodipine Sustained-Release Tablet Sales by Type

    7.3 Europe Felodipine Sustained-Release Tablet Sales by Application

    7.4 Germany

    7.5 France

    7.6 UK

    7.7 Italy

    7.8 Russia

8 Middle East & Africa

    8.1 Middle East & Africa Felodipine Sustained-Release Tablet by Country

        8.1.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2019-2024)

        8.1.2 Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2019-2024)

    8.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type

    8.3 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application

    8.4 Egypt

    8.5 South Africa

    8.6 Israel

    8.7 Turkey

    8.8 GCC Countries

9 Market Drivers, Challenges and Trends

    9.1 Market Drivers & Growth Opportunities

    9.2 Market Challenges & Risks

    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

    10.1 Raw Material and Suppliers

    10.2 Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet

    10.3 Manufacturing Process Analysis of Felodipine Sustained-Release Tablet

    10.4 Industry Chain Structure of Felodipine Sustained-Release Tablet

11 Marketing, Distributors and Customer

    11.1 Sales Channel

        11.1.1 Direct Channels

        11.1.2 Indirect Channels

    11.2 Felodipine Sustained-Release Tablet Distributors

    11.3 Felodipine Sustained-Release Tablet Customer

12 World Forecast Review for Felodipine Sustained-Release Tablet by Geographic Region

    12.1 Global Felodipine Sustained-Release Tablet Market Size Forecast by Region

        12.1.1 Global Felodipine Sustained-Release Tablet Forecast by Region (2025-2030)

        12.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue Forecast by Region (2025-2030)

    12.2 Americas Forecast by Country

    12.3 APAC Forecast by Region

    12.4 Europe Forecast by Country

    12.5 Middle East & Africa Forecast by Country

    12.6 Global Felodipine Sustained-Release Tablet Forecast by Type

    12.7 Global Felodipine Sustained-Release Tablet Forecast by Application

13 Key Players Analysis

    13.1 Astrazeneca

        13.1.1 Astrazeneca Company Information

        13.1.2 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolios and Specifications

        13.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)

        13.1.4 Astrazeneca Main Business Overview

        13.1.5 Astrazeneca Latest Developments

    13.2 NanJing Easeheal Phaemaecutical

        13.2.1 NanJing Easeheal Phaemaecutical Company Information

        13.2.2 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications

        13.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)

        13.2.4 NanJing Easeheal Phaemaecutical Main Business Overview

        13.2.5 NanJing Easeheal Phaemaecutical Latest Developments

    13.3 SHANXI KANGBO BIOLOGICAL PRODUCT

        13.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information

        13.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolios and Specifications

        13.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)

        13.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Main Business Overview

        13.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments

    13.4 Lifeon

        13.4.1 Lifeon Company Information

        13.4.2 Lifeon Felodipine Sustained-Release Tablet Product Portfolios and Specifications

        13.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)

        13.4.4 Lifeon Main Business Overview

        13.4.5 Lifeon Latest Developments

    13.5 Changzhou Siyao Pharmaceutical

        13.5.1 Changzhou Siyao Pharmaceutical Company Information

        13.5.2 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications

        13.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)

        13.5.4 Changzhou Siyao Pharmaceutical Main Business Overview

        13.5.5 Changzhou Siyao Pharmaceutical Latest Developments

    13.6 Mylan

        13.6.1 Mylan Company Information

        13.6.2 Mylan Felodipine Sustained-Release Tablet Product Portfolios and Specifications

        13.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)

        13.6.4 Mylan Main Business Overview

        13.6.5 Mylan Latest Developments

    13.7 Sandoz

        13.7.1 Sandoz Company Information

        13.7.2 Sandoz Felodipine Sustained-Release Tablet Product Portfolios and Specifications

        13.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)

        13.7.4 Sandoz Main Business Overview

        13.7.5 Sandoz Latest Developments

14 Research Findings and Conclusion

List of Tables

    Table 1. Felodipine Sustained-Release Tablet Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Felodipine Sustained-Release Tablet Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of 2.5mg Per Tablet

    Table 4. Major Players of 5mg Per Tablet

    Table 5. Major Players of Others

    Table 6. Global Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)

    Table 7. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)

    Table 8. Global Felodipine Sustained-Release Tablet Revenue by Type (2019-2024) & ($ million)

    Table 9. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2019-2024)

    Table 10. Global Felodipine Sustained-Release Tablet Sale Price by Type (2019-2024) & (US$/Unit)

    Table 11. Global Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)

    Table 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)

    Table 13. Global Felodipine Sustained-Release Tablet Revenue by Application (2019-2024)

    Table 14. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2019-2024)

    Table 15. Global Felodipine Sustained-Release Tablet Sale Price by Application (2019-2024) & (US$/Unit)

    Table 16. Global Felodipine Sustained-Release Tablet Sales by Company (2019-2024) & (K Units)

    Table 17. Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2019-2024)

    Table 18. Global Felodipine Sustained-Release Tablet Revenue by Company (2019-2024) ($ Millions)

    Table 19. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2019-2024)

    Table 20. Global Felodipine Sustained-Release Tablet Sale Price by Company (2019-2024) & (US$/Unit)

    Table 21. Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution and Sales Area

    Table 22. Players Felodipine Sustained-Release Tablet Products Offered

    Table 23. Felodipine Sustained-Release Tablet Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 24. New Products and Potential Entrants

    Table 25. Mergers & Acquisitions, Expansion

    Table 26. Global Felodipine Sustained-Release Tablet Sales by Geographic Region (2019-2024) & (K Units)

    Table 27. Global Felodipine Sustained-Release Tablet Sales Market Share Geographic Region (2019-2024)

    Table 28. Global Felodipine Sustained-Release Tablet Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 29. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region (2019-2024)

    Table 30. Global Felodipine Sustained-Release Tablet Sales by Country/Region (2019-2024) & (K Units)

    Table 31. Global Felodipine Sustained-Release Tablet Sales Market Share by Country/Region (2019-2024)

    Table 32. Global Felodipine Sustained-Release Tablet Revenue by Country/Region (2019-2024) & ($ millions)

    Table 33. Global Felodipine Sustained-Release Tablet Revenue Market Share by Country/Region (2019-2024)

    Table 34. Americas Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)

    Table 35. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2024)

    Table 36. Americas Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & ($ Millions)

    Table 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2024)

    Table 38. Americas Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)

    Table 39. Americas Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)

    Table 40. APAC Felodipine Sustained-Release Tablet Sales by Region (2019-2024) & (K Units)

    Table 41. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region (2019-2024)

    Table 42. APAC Felodipine Sustained-Release Tablet Revenue by Region (2019-2024) & ($ Millions)

    Table 43. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Region (2019-2024)

    Table 44. APAC Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)

    Table 45. APAC Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)

    Table 46. Europe Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)

    Table 47. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2024)

    Table 48. Europe Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & ($ Millions)

    Table 49. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2024)

    Table 50. Europe Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)

    Table 51. Europe Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)

    Table 52. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)

    Table 53. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2024)

    Table 54. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & ($ Millions)

    Table 55. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2024)

    Table 56. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)

    Table 57. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)

    Table 58. Key Market Drivers & Growth Opportunities of Felodipine Sustained-Release Tablet

    Table 59. Key Market Challenges & Risks of Felodipine Sustained-Release Tablet

    Table 60. Key Industry Trends of Felodipine Sustained-Release Tablet

    Table 61. Felodipine Sustained-Release Tablet Raw Material

    Table 62. Key Suppliers of Raw Materials

    Table 63. Felodipine Sustained-Release Tablet Distributors List

    Table 64. Felodipine Sustained-Release Tablet Customer List

    Table 65. Global Felodipine Sustained-Release Tablet Sales Forecast by Region (2025-2030) & (K Units)

    Table 66. Global Felodipine Sustained-Release Tablet Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 67. Americas Felodipine Sustained-Release Tablet Sales Forecast by Country (2025-2030) & (K Units)

    Table 68. Americas Felodipine Sustained-Release Tablet Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 69. APAC Felodipine Sustained-Release Tablet Sales Forecast by Region (2025-2030) & (K Units)

    Table 70. APAC Felodipine Sustained-Release Tablet Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 71. Europe Felodipine Sustained-Release Tablet Sales Forecast by Country (2025-2030) & (K Units)

    Table 72. Europe Felodipine Sustained-Release Tablet Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 73. Middle East & Africa Felodipine Sustained-Release Tablet Sales Forecast by Country (2025-2030) & (K Units)

    Table 74. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 75. Global Felodipine Sustained-Release Tablet Sales Forecast by Type (2025-2030) & (K Units)

    Table 76. Global Felodipine Sustained-Release Tablet Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 77. Global Felodipine Sustained-Release Tablet Sales Forecast by Application (2025-2030) & (K Units)

    Table 78. Global Felodipine Sustained-Release Tablet Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 79. Astrazeneca Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

    Table 80. Astrazeneca Felodipine Sustained-Release Tablet Product Portfolios and Specifications

    Table 81. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 82. Astrazeneca Main Business

    Table 83. Astrazeneca Latest Developments

    Table 84. NanJing Easeheal Phaemaecutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

    Table 85. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications

    Table 86. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 87. NanJing Easeheal Phaemaecutical Main Business

    Table 88. NanJing Easeheal Phaemaecutical Latest Developments

    Table 89. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

    Table 90. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolios and Specifications

    Table 91. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 92. SHANXI KANGBO BIOLOGICAL PRODUCT Main Business

    Table 93. SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments

    Table 94. Lifeon Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

    Table 95. Lifeon Felodipine Sustained-Release Tablet Product Portfolios and Specifications

    Table 96. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 97. Lifeon Main Business

    Table 98. Lifeon Latest Developments

    Table 99. Changzhou Siyao Pharmaceutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

    Table 100. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications

    Table 101. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 102. Changzhou Siyao Pharmaceutical Main Business

    Table 103. Changzhou Siyao Pharmaceutical Latest Developments

    Table 104. Mylan Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

    Table 105. Mylan Felodipine Sustained-Release Tablet Product Portfolios and Specifications

    Table 106. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 107. Mylan Main Business

    Table 108. Mylan Latest Developments

    Table 109. Sandoz Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

    Table 110. Sandoz Felodipine Sustained-Release Tablet Product Portfolios and Specifications

    Table 111. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 112. Sandoz Main Business

    Table 113. Sandoz Latest Developments

List of Figures

    Figure 1. Picture of Felodipine Sustained-Release Tablet

    Figure 2. Felodipine Sustained-Release Tablet Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Felodipine Sustained-Release Tablet Sales Growth Rate 2019-2030 (K Units)

    Figure 7. Global Felodipine Sustained-Release Tablet Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Felodipine Sustained-Release Tablet Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of 2.5mg Per Tablet

    Figure 10. Product Picture of 5mg Per Tablet

    Figure 11. Product Picture of Others

    Figure 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Type in 2023

    Figure 13. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2019-2024)

    Figure 14. Felodipine Sustained-Release Tablet Consumed in Treat High Blood Pressure

    Figure 15. Global Felodipine Sustained-Release Tablet Market: Treat High Blood Pressure (2019-2024) & (K Units)

    Figure 16. Felodipine Sustained-Release Tablet Consumed in Relieve Angina

    Figure 17. Global Felodipine Sustained-Release Tablet Market: Relieve Angina (2019-2024) & (K Units)

    Figure 18. Felodipine Sustained-Release Tablet Consumed in Others

    Figure 19. Global Felodipine Sustained-Release Tablet Market: Others (2019-2024) & (K Units)

    Figure 20. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2023)

    Figure 21. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application in 2023

    Figure 22. Felodipine Sustained-Release Tablet Sales Market by Company in 2023 (K Units)

    Figure 23. Global Felodipine Sustained-Release Tablet Sales Market Share by Company in 2023

    Figure 24. Felodipine Sustained-Release Tablet Revenue Market by Company in 2023 ($ Million)

    Figure 25. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company in 2023

    Figure 26. Global Felodipine Sustained-Release Tablet Sales Market Share by Geographic Region (2019-2024)

    Figure 27. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region in 2023

    Figure 28. Americas Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)

    Figure 29. Americas Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)

    Figure 30. APAC Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)

    Figure 31. APAC Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)

    Figure 32. Europe Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)

    Figure 33. Europe Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)

    Figure 34. Middle East & Africa Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)

    Figure 35. Middle East & Africa Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)

    Figure 36. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country in 2023

    Figure 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2023

    Figure 38. Americas Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)

    Figure 39. Americas Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)

    Figure 40. United States Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 41. Canada Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 42. Mexico Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 43. Brazil Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 44. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region in 2023

    Figure 45. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Regions in 2023

    Figure 46. APAC Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)

    Figure 47. APAC Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)

    Figure 48. China Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 49. Japan Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 50. South Korea Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 51. Southeast Asia Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 52. India Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 53. Australia Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 54. China Taiwan Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 55. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country in 2023

    Figure 56. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2023

    Figure 57. Europe Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)

    Figure 58. Europe Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)

    Figure 59. Germany Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 60. France Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 61. UK Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 62. Italy Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 63. Russia Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 64. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country in 2023

    Figure 65. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2023

    Figure 66. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)

    Figure 67. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)

    Figure 68. Egypt Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 69. South Africa Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 70. Israel Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 71. Turkey Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 72. GCC Country Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)

    Figure 73. Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet in 2023

    Figure 74. Manufacturing Process Analysis of Felodipine Sustained-Release Tablet

    Figure 75. Industry Chain Structure of Felodipine Sustained-Release Tablet

    Figure 76. Channels of Distribution

    Figure 77. Global Felodipine Sustained-Release Tablet Sales Market Forecast by Region (2025-2030)

    Figure 78. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Region (2025-2030)

    Figure 79. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Type (2025-2030)

    Figure 80. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Type (2025-2030)

    Figure 81. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Application (2025-2030)

    Figure 82. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Application (2025-2030)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"Astrazeneca"|||"NanJing Easeheal Phaemaecutical"|||"SHANXI KANGBO BIOLOGICAL PRODUCT"|||"Lifeon"|||"Changzhou Siyao Pharmaceutical"|||"Mylan"|||"Sandoz"
Frequently Asked Questions
Felodipine Sustained-Release Tablet report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Felodipine Sustained-Release Tablet report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Felodipine Sustained-Release Tablet report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports